Related Experiment Video
Updated: Sep 28, 2025

10:47
Using Bioluminescent Imaging to Investigate Synergism Between Streptococcus pneumoniae and Influenza A Virus in Infant Mice
Published on: April 14, 2011
17.0K
Apnea in a Two-Week-Old Infant Infected with SARS-CoV-2 and Influenza B
Radhika Maddali1, Kelly L Cervellione2, Lily Q Lew1
1Department of Pediatrics, Flushing Hospital Medical Center, Flushing, NY 11355, USA.
Case Reports in Pediatrics
|March 28, 2022
Summary
Data on infant COVID-19 symptoms is limited. This case study details a rare coinfection of severe acute respiratory syndrome-related coronavirus 2 (SARS-CoV-2) and influenza B in a neonate presenting with apnea.
Area of Science:
- Neonatology
- Pediatric Infectious Diseases
- Virology
Background:
- Limited data exists on the clinical presentation and outcomes of coronavirus disease 2019 (COVID-19) in infants.
- Coinfection with severe acute respiratory syndrome-related coronavirus 2 (SARS-CoV-2) and influenza B is infrequently reported in neonates.
- Neonatal apnea is a known, though rare, presenting symptom in infants with SARS-CoV-2 infection.
Observation:
- A 2-week-old, otherwise healthy, full-term infant presented with apnea.
- Diagnostic evaluation revealed coinfection with SARS-CoV-2 and influenza B.
- The infant experienced a mild clinical course.
Findings:
- This case highlights a rare instance of neonatal coinfection with SARS-CoV-2 and influenza B.
- Apnea, a rare symptom, was the primary presenting complaint.
- The infant demonstrated a favorable outcome with complete recovery.
Implications:
- This case contributes to the limited understanding of SARS-CoV-2 and influenza B coinfection in neonates.
- It underscores the importance of considering coinfections in infants presenting with respiratory symptoms like apnea.
- Further research is needed to elucidate the clinical spectrum and management of such coinfections in this vulnerable population.
Related Concept Videos
Acute Respiratory Failure-II
408
Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
408
Acute Respiratory Failure-I
369
Acute respiratory failure is a condition characterized by the inability of the lungs to perform their primary function: gas exchange. This failure leads to insufficient oxygen levels (hypoxemia) in the blood, elevated carbon dioxide levels (hypercapnia), or both, causing critical impairment in organ function.
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
369
Acute Respiratory Failure-III
368
Hypercapnic respiratory failure, also known as Type 2 or ventilatory respiratory failure, is a severe condition characterized by the body's inability to effectively remove carbon dioxide (CO2) from the bloodstream. It leads to an arterial CO2 pressure (PaCO2) exceeding 45 mmHg and a blood pH above 7.35. This situation indicates that the body's ventilatory demand, or the ventilation needed to maintain normal PaCO2 levels, surpasses its supply or the maximum gas flow achievable without...
368
Acute Respiratory Failure-V
223
The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Ensure that patients are monitored continuously for their response to therapy, including changes in...
223
Pulmonary Cycle: Exhalation
1.9K
In terms of human respiration, the act of expelling air, known as exhalation (or expiration), operates on the principle of pressure gradients. During expiration, the pressure within the lungs exceeds that of the surrounding atmosphere. Under normal conditions, quiet breathing involves passive exhalation and is free of muscular contractions. This is because the exhalation process is driven by the natural elastic recoil of the lungs and chest wall, both of which have an inherent tendency to...
1.9K
Acute Respiratory Failure-IV
256
Respiratory failure can manifest suddenly or gradually, characterized by a rapid decline in PaO2 and a rapid rise in PaCO2. This situation indicates a severe respiratory problem that may quickly become a life-threatening emergency. One of the early signs of hypoxemic Acute Respiratory Failure (ARF) is a change in mental status due to the brain's sensitivity to oxygen levels and changes in acid-base balance. Symptoms such as restlessness, confusion, and agitation suggest inadequate oxygen...
256

